List J - Search Results

1

Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes.

Sjöström CD, Johansson P, Ptaszynska A, List J, Johnsson E. Sjöström CD, et al. Among authors: list j. Diab Vasc Dis Res. 2015 Sep;12(5):352-8. doi: 10.1177/1479164115585298. Epub 2015 May 25. Diab Vasc Dis Res. 2015. PMID: 26008804 Free article.

2

Effects of dapagliflozin on cardiovascular risk factors.

Ptaszynska A, Hardy E, Johnsson E, Parikh S, List J. Ptaszynska A, et al. Among authors: list j. Postgrad Med. 2013 May;125(3):181-9. doi: 10.3810/pgm.2013.05.2667. Postgrad Med. 2013. PMID: 23748519 Review.

3

Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin.

Johnsson KM, Ptaszynska A, Schmitz B, Sugg J, Parikh SJ, List JF. Johnsson KM, et al. Among authors: list jf. J Diabetes Complications. 2013 Sep-Oct;27(5):479-84. doi: 10.1016/j.jdiacomp.2013.04.012. Epub 2013 Jun 24. J Diabetes Complications. 2013. PMID: 23806570

4

Urinary tract infections in patients with diabetes treated with dapagliflozin.

Johnsson KM, Ptaszynska A, Schmitz B, Sugg J, Parikh SJ, List JF. Johnsson KM, et al. Among authors: list jf. J Diabetes Complications. 2013 Sep-Oct;27(5):473-8. doi: 10.1016/j.jdiacomp.2013.05.004. Epub 2013 Jul 10. J Diabetes Complications. 2013. PMID: 23849632

5

Safety profile of dapagliflozin for type 2 diabetes: pooled analysis of clinical studies for overall safety and rare events.

Ptaszynska A, Johnsson KM, Parikh SJ, de Bruin TW, Apanovitch AM, List JF. Ptaszynska A, et al. Among authors: list jf. Drug Saf. 2014 Oct;37(10):815-29. doi: 10.1007/s40264-014-0213-4. Drug Saf. 2014. PMID: 25096959

6

Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III study.

Ji L, Ma J, Li H, Mansfield TA, T'joen CL, Iqbal N, Ptaszynska A, List JF. Ji L, et al. Among authors: list jf. Clin Ther. 2014 Jan 1;36(1):84-100.e9. doi: 10.1016/j.clinthera.2013.11.002. Epub 2013 Dec 28. Clin Ther. 2014. PMID: 24378206 Free article. Clinical Trial.

7

Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial.

Henry RR, Murray AV, Marmolejo MH, Hennicken D, Ptaszynska A, List JF. Henry RR, et al. Among authors: list jf. Int J Clin Pract. 2012 May;66(5):446-56. doi: 10.1111/j.1742-1241.2012.02911.x. Epub 2012 Mar 13. Int J Clin Pract. 2012. PMID: 22413962 Clinical Trial.

8

Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double-blind placebo-controlled 102-week trial.

Bailey CJ, Morales Villegas EC, Woo V, Tang W, Ptaszynska A, List JF. Bailey CJ, et al. Among authors: list jf. Diabet Med. 2015 Apr;32(4):531-41. doi: 10.1111/dme.12624. Epub 2014 Nov 22. Diabet Med. 2015. PMID: 25381876 Clinical Trial.

9

Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight.

Zhang L, Feng Y, List J, Kasichayanula S, Pfister M. Zhang L, et al. Among authors: list j. Diabetes Obes Metab. 2010 Jun;12(6):510-6. doi: 10.1111/j.1463-1326.2010.01216.x. Diabetes Obes Metab. 2010. PMID: 20518806 Clinical Trial.

10

Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.

Henry RR, Rosenstock J, Edelman S, Mudaliar S, Chalamandaris AG, Kasichayanula S, Bogle A, Iqbal N, List J, Griffen SC. Henry RR, et al. Among authors: list j. Diabetes Care. 2015 Mar;38(3):412-9. doi: 10.2337/dc13-2955. Epub 2014 Sep 30. Diabetes Care. 2015. PMID: 25271207 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters